For informational and research purposes only. Not medical advice. Content is aggregated from public sources. Always consult a qualified healthcare provider.
Performance & Growth Hormone · Comparison

GHRP-2 vs Sermorelin

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

GHRP-2Sermorelin
CategoryPerformance & Growth HormonePerformance & Growth Hormone
Also known asGrowth Hormone Releasing Peptide-2, Pralmorelin, KP 102GHRH 1-29, GRF 1-29 NH2, Geref
EvidencePreclinical onlyFDA-approved
Dosing range100mcg–300mcg mcg, 1–3 times daily, on an empty stomach100mcg–500mcg mcg, once daily (before sleep)
AdministrationSubcutaneous injection, Intramuscular injectionSubcutaneous injection
Key side effectsIncreased hunger (less than GHRP-6), Elevated cortisol and prolactin at high doses, Water retention, Injection site irritationInjection site redness, Headache, Flushing, Dizziness
Cited sources3 references1 reference

Key differences

  • Evidence level differs: GHRP-2 is preclinical only, while Sermorelin is fda-approved.
  • Administration: GHRP-2 — Subcutaneous injection, Intramuscular injection; Sermorelin — Subcutaneous injection.
  • Frequency: GHRP-2 is typically 1–3 times daily, on an empty stomach; Sermorelin is once daily (before sleep).
  • Research depth: this profile cites 3 sources for GHRP-2 vs 1 for Sermorelin.

How each works

GHRP-2

GHRP-2 has been extensively studied in both animal and human subjects. Clinical trials have demonstrated significant GH elevation in healthy adults, with a peak GH pulse occurring 15–30 minutes post-injection. Studies show it increases IGF-1 levels with chronic use and may have mild cardioprotective properties. Unlike GHRP-6, it has a lower propensity to stimulate cortisol and prolactin at standard doses.

Sermorelin

Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.

Read the full GHRP-2 profileRead the full Sermorelin profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.